MTOR and osteosarcoma: Furthermore, HSP90 has been implicated in chemotherapy resistance in osteosarcoma cells, where it inhibits apoptosis via the JNK/P38 pathway and promotes autophagy through the PI3K/Akt/mTOR pathway [34].